img

Global Lung Disease Therapeutic Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lung Disease Therapeutic Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Lung Disease Therapeutic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lung Disease Therapeutic Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lung Disease Therapeutic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Segment by Type
Corticosteroids
Bronchodilator Medications
Mucolytics
Antimicrobial Medications
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lung Disease Therapeutic Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lung Disease Therapeutic Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lung Disease Therapeutic Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lung Disease Therapeutic Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lung Disease Therapeutic Drug introduction, etc. Lung Disease Therapeutic Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Lung Disease Therapeutic Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Lung Disease Therapeutic Drug Market Overview
1.1 Lung Disease Therapeutic Drug Product Overview
1.2 Lung Disease Therapeutic Drug Market Segment by Type
1.2.1 Corticosteroids
1.2.2 Bronchodilator Medications
1.2.3 Mucolytics
1.2.4 Antimicrobial Medications
1.2.5 Others
1.3 Global Lung Disease Therapeutic Drug Market Size by Type
1.3.1 Global Lung Disease Therapeutic Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Lung Disease Therapeutic Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Lung Disease Therapeutic Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lung Disease Therapeutic Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Lung Disease Therapeutic Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Lung Disease Therapeutic Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Lung Disease Therapeutic Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Lung Disease Therapeutic Drug Sales Breakdown by Type (2018-2024)
2 Global Lung Disease Therapeutic Drug Market Competition by Company
2.1 Global Top Players by Lung Disease Therapeutic Drug Sales (2018-2024)
2.2 Global Top Players by Lung Disease Therapeutic Drug Revenue (2018-2024)
2.3 Global Top Players by Lung Disease Therapeutic Drug Price (2018-2024)
2.4 Global Top Manufacturers Lung Disease Therapeutic Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lung Disease Therapeutic Drug Market Competitive Situation and Trends
2.5.1 Lung Disease Therapeutic Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Lung Disease Therapeutic Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Disease Therapeutic Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Lung Disease Therapeutic Drug Market
2.8 Key Manufacturers Lung Disease Therapeutic Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lung Disease Therapeutic Drug Status and Outlook by Region
3.1 Global Lung Disease Therapeutic Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Lung Disease Therapeutic Drug Historic Market Size by Region
3.2.1 Global Lung Disease Therapeutic Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Lung Disease Therapeutic Drug Sales in Value by Region (2018-2024)
3.2.3 Global Lung Disease Therapeutic Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Lung Disease Therapeutic Drug Forecasted Market Size by Region
3.3.1 Global Lung Disease Therapeutic Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Lung Disease Therapeutic Drug Sales in Value by Region (2024-2029)
3.3.3 Global Lung Disease Therapeutic Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Lung Disease Therapeutic Drug by Application
4.1 Lung Disease Therapeutic Drug Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Lung Disease Therapeutic Drug Market Size by Application
4.2.1 Global Lung Disease Therapeutic Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Lung Disease Therapeutic Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Lung Disease Therapeutic Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lung Disease Therapeutic Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Lung Disease Therapeutic Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Lung Disease Therapeutic Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Lung Disease Therapeutic Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Lung Disease Therapeutic Drug Sales Breakdown by Application (2018-2024)
5 North America Lung Disease Therapeutic Drug by Country
5.1 North America Lung Disease Therapeutic Drug Historic Market Size by Country
5.1.1 North America Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Lung Disease Therapeutic Drug Sales in Value by Country (2018-2024)
5.2 North America Lung Disease Therapeutic Drug Forecasted Market Size by Country
5.2.1 North America Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Lung Disease Therapeutic Drug Sales in Value by Country (2024-2029)
6 Europe Lung Disease Therapeutic Drug by Country
6.1 Europe Lung Disease Therapeutic Drug Historic Market Size by Country
6.1.1 Europe Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Lung Disease Therapeutic Drug Sales in Value by Country (2018-2024)
6.2 Europe Lung Disease Therapeutic Drug Forecasted Market Size by Country
6.2.1 Europe Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Lung Disease Therapeutic Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Lung Disease Therapeutic Drug by Region
7.1 Asia-Pacific Lung Disease Therapeutic Drug Historic Market Size by Region
7.1.1 Asia-Pacific Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Lung Disease Therapeutic Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Lung Disease Therapeutic Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Lung Disease Therapeutic Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Lung Disease Therapeutic Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Lung Disease Therapeutic Drug Sales in Value by Region (2024-2029)
8 Latin America Lung Disease Therapeutic Drug by Country
8.1 Latin America Lung Disease Therapeutic Drug Historic Market Size by Country
8.1.1 Latin America Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Lung Disease Therapeutic Drug Sales in Value by Country (2018-2024)
8.2 Latin America Lung Disease Therapeutic Drug Forecasted Market Size by Country
8.2.1 Latin America Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Lung Disease Therapeutic Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Lung Disease Therapeutic Drug by Country
9.1 Middle East and Africa Lung Disease Therapeutic Drug Historic Market Size by Country
9.1.1 Middle East and Africa Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Lung Disease Therapeutic Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Lung Disease Therapeutic Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Lung Disease Therapeutic Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Lung Disease Therapeutic Drug Products Offered
10.1.5 GSK Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Lung Disease Therapeutic Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novartis Lung Disease Therapeutic Drug Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Mylan Lung Disease Therapeutic Drug Products Offered
10.5.5 Mylan Recent Development
10.6 Vertex Pharmaceuticals
10.6.1 Vertex Pharmaceuticals Company Information
10.6.2 Vertex Pharmaceuticals Introduction and Business Overview
10.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Products Offered
10.6.5 Vertex Pharmaceuticals Recent Development
10.7 F. Hoffman La Roche
10.7.1 F. Hoffman La Roche Company Information
10.7.2 F. Hoffman La Roche Introduction and Business Overview
10.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Products Offered
10.7.5 F. Hoffman La Roche Recent Development
10.8 Teva Pharmaceuticals
10.8.1 Teva Pharmaceuticals Company Information
10.8.2 Teva Pharmaceuticals Introduction and Business Overview
10.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Products Offered
10.8.5 Teva Pharmaceuticals Recent Development
10.9 Cipla
10.9.1 Cipla Company Information
10.9.2 Cipla Introduction and Business Overview
10.9.3 Cipla Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Cipla Lung Disease Therapeutic Drug Products Offered
10.9.5 Cipla Recent Development
10.10 Fibrogen
10.10.1 Fibrogen Company Information
10.10.2 Fibrogen Introduction and Business Overview
10.10.3 Fibrogen Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Fibrogen Lung Disease Therapeutic Drug Products Offered
10.10.5 Fibrogen Recent Development
10.11 Liminal Biosciences
10.11.1 Liminal Biosciences Company Information
10.11.2 Liminal Biosciences Introduction and Business Overview
10.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Products Offered
10.11.5 Liminal Biosciences Recent Development
10.12 PharmAkea Therapeutics
10.12.1 PharmAkea Therapeutics Company Information
10.12.2 PharmAkea Therapeutics Introduction and Business Overview
10.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Products Offered
10.12.5 PharmAkea Therapeutics Recent Development
10.13 IQVIA
10.13.1 IQVIA Company Information
10.13.2 IQVIA Introduction and Business Overview
10.13.3 IQVIA Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 IQVIA Lung Disease Therapeutic Drug Products Offered
10.13.5 IQVIA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lung Disease Therapeutic Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lung Disease Therapeutic Drug Industrial Chain Analysis
11.4 Lung Disease Therapeutic Drug Market Dynamics
11.4.1 Lung Disease Therapeutic Drug Industry Trends
11.4.2 Lung Disease Therapeutic Drug Market Drivers
11.4.3 Lung Disease Therapeutic Drug Market Challenges
11.4.4 Lung Disease Therapeutic Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lung Disease Therapeutic Drug Distributors
12.3 Lung Disease Therapeutic Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Corticosteroids
Table 2. Major Company of Bronchodilator Medications
Table 3. Major Company of Mucolytics
Table 4. Major Company of Antimicrobial Medications
Table 5. Major Company of Others
Table 6. Global Lung Disease Therapeutic Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 8. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Lung Disease Therapeutic Drug Market Share in Value by Type (2018-2024)
Table 11. Global Lung Disease Therapeutic Drug Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 13. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Type (2024-2029)
Table 16. Global Lung Disease Therapeutic Drug Price by Type (2024-2029) & (US$/Unit)
Table 17. North America Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 18. North America Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Lung Disease Therapeutic Drug Sales (K Units) by Type (2018-2024)
Table 20. Europe Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Lung Disease Therapeutic Drug Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Lung Disease Therapeutic Drug Sales (K Units) by Type (2018-2024)
Table 24. Latin America Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Lung Disease Therapeutic Drug Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Lung Disease Therapeutic Drug Sales by Company (2018-2024) & (K Units)
Table 28. Global Lung Disease Therapeutic Drug Sales Share by Company (2018-2024)
Table 29. Global Lung Disease Therapeutic Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Lung Disease Therapeutic Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Lung Disease Therapeutic Drug Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Lung Disease Therapeutic Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Lung Disease Therapeutic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Disease Therapeutic Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Lung Disease Therapeutic Drug Market
Table 36. Key Manufacturers Lung Disease Therapeutic Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Lung Disease Therapeutic Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (K Units)
Table 40. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (K Units)
Table 45. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Region (2024-2029)
Table 48. Global Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global Lung Disease Therapeutic Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 51. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Lung Disease Therapeutic Drug Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 56. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Application (2024-2029)
Table 59. Global Lung Disease Therapeutic Drug Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Lung Disease Therapeutic Drug Sales by Application (2018-2024) (K Units)
Table 61. North America Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Lung Disease Therapeutic Drug Sales by Application (2018-2024) (K Units)
Table 63. Europe Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Lung Disease Therapeutic Drug Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Lung Disease Therapeutic Drug Sales by Application (2018-2024) (K Units)
Table 67. Latin America Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Lung Disease Therapeutic Drug Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 71. North America Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 75. North America Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 79. Europe Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 83. Europe Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 99. Latin America Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Value by Country (2024-2029)
Table 110. GSK Company Information
Table 111. GSK Introduction and Business Overview
Table 112. GSK Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. GSK Lung Disease Therapeutic Drug Product
Table 114. GSK Recent Development
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Introduction and Business Overview
Table 117. AstraZeneca Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. AstraZeneca Lung Disease Therapeutic Drug Product
Table 119. AstraZeneca Recent Development
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Introduction and Business Overview
Table 122. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Boehringer Ingelheim Lung Disease Therapeutic Drug Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Novartis Company Information
Table 126. Novartis Introduction and Business Overview
Table 127. Novartis Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Novartis Lung Disease Therapeutic Drug Product
Table 129. Novartis Recent Development
Table 130. Mylan Company Information
Table 131. Mylan Introduction and Business Overview
Table 132. Mylan Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Mylan Lung Disease Therapeutic Drug Product
Table 134. Mylan Recent Development
Table 135. Vertex Pharmaceuticals Company Information
Table 136. Vertex Pharmaceuticals Introduction and Business Overview
Table 137. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product
Table 139. Vertex Pharmaceuticals Recent Development
Table 140. F. Hoffman La Roche Company Information
Table 141. F. Hoffman La Roche Introduction and Business Overview
Table 142. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. F. Hoffman La Roche Lung Disease Therapeutic Drug Product
Table 144. F. Hoffman La Roche Recent Development
Table 145. Teva Pharmaceuticals Company Information
Table 146. Teva Pharmaceuticals Introduction and Business Overview
Table 147. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product
Table 149. Teva Pharmaceuticals Recent Development
Table 150. Cipla Company Information
Table 151. Cipla Introduction and Business Overview
Table 152. Cipla Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Cipla Lung Disease Therapeutic Drug Product
Table 154. Cipla Recent Development
Table 155. Fibrogen Company Information
Table 156. Fibrogen Introduction and Business Overview
Table 157. Fibrogen Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Fibrogen Lung Disease Therapeutic Drug Product
Table 159. Fibrogen Recent Development
Table 160. Liminal Biosciences Company Information
Table 161. Liminal Biosciences Introduction and Business Overview
Table 162. Liminal Biosciences Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Liminal Biosciences Lung Disease Therapeutic Drug Product
Table 164. Liminal Biosciences Recent Development
Table 165. PharmAkea Therapeutics Company Information
Table 166. PharmAkea Therapeutics Introduction and Business Overview
Table 167. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product
Table 169. PharmAkea Therapeutics Recent Development
Table 170. IQVIA Company Information
Table 171. IQVIA Introduction and Business Overview
Table 172. IQVIA Lung Disease Therapeutic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. IQVIA Lung Disease Therapeutic Drug Product
Table 174. IQVIA Recent Development
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Lung Disease Therapeutic Drug Market Trends
Table 178. Lung Disease Therapeutic Drug Market Drivers
Table 179. Lung Disease Therapeutic Drug Market Challenges
Table 180. Lung Disease Therapeutic Drug Market Restraints
Table 181. Lung Disease Therapeutic Drug Distributors List
Table 182. Lung Disease Therapeutic Drug Downstream Customers
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Disease Therapeutic Drug Product Picture
Figure 2. Global Lung Disease Therapeutic Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lung Disease Therapeutic Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Lung Disease Therapeutic Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Corticosteroids
Figure 6. Global Corticosteroids Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Bronchodilator Medications
Figure 8. Global Bronchodilator Medications Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Mucolytics
Figure 10. Global Mucolytics Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Antimicrobial Medications
Figure 12. Global Antimicrobial Medications Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global Lung Disease Therapeutic Drug Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Lung Disease Therapeutic Drug Sales Market Share by Type in 2022 & 2029
Figure 17. North America Lung Disease Therapeutic Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Lung Disease Therapeutic Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Lung Disease Therapeutic Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Lung Disease Therapeutic Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Lung Disease Therapeutic Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Lung Disease Therapeutic Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Disease Therapeutic Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Disease Therapeutic Drug Revenue in 2022
Figure 29. Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital Pharmacies
Figure 31. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Retail Pharmacies
Figure 33. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Online Pharmacies
Figure 35. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Lung Disease Therapeutic Drug Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Lung Disease Therapeutic Drug Sales Market Share by Application in 2022 & 2029
Figure 38. North America Lung Disease Therapeutic Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Lung Disease Therapeutic Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Lung Disease Therapeutic Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Lung Disease Therapeutic Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Lung Disease Therapeutic Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Lung Disease Therapeutic Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Lung Disease Therapeutic Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Lung Disease Therapeutic Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Lung Disease Therapeutic Drug Manufacturing Cost Structure
Figure 49. Lung Disease Therapeutic Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries